These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9403266)
1. Bactericidal activities of povidone-iodine against Mycobacterium. Rikimaru T; Kondo M; Kondo S; Oizumi K Dermatology; 1997; 195 Suppl 2():104-6. PubMed ID: 9403266 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal activities of commonly used antiseptics against multidrug-resistant mycobacterium tuberculosis. Rikimaru T; Kondo M; Kajimura K; Hashimoto K; Oyamada K; Sagawa K; Tanoue S; Oizumi K Dermatology; 2002; 204 Suppl 1():15-20. PubMed ID: 12011515 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of common antiseptics against mycobacteria. Rikimaru T; Kondo M; Kondo S; Oizumi K Int J Tuberc Lung Dis; 2000 Jun; 4(6):570-6. PubMed ID: 10864189 [TBL] [Abstract][Full Text] [Related]
5. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Kunisada T; Yamada K; Oda S; Hara O Dermatology; 1997; 195 Suppl 2():14-8. PubMed ID: 9403250 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of common antiseptics against multidrug-resistant Mycobacterium tuberculosis. Rikimaru T; Kondo M; Kajimura K; Hashimoto K; Oyamada K; Miyazaki S; Sagawa K; Aizawa H; Oizumi K Int J Tuberc Lung Dis; 2002 Sep; 6(9):763-70. PubMed ID: 12234131 [TBL] [Abstract][Full Text] [Related]
8. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. Steadham JE; Stall SK; Simmank JL Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species. Disratthakit A; Doi N Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Kawana R; Kitamura T; Nakagomi O; Matsumoto I; Arita M; Yoshihara N; Yanagi K; Yamada A; Morita O; Yoshida Y; Furuya Y; Chiba S Dermatology; 1997; 195 Suppl 2():29-35. PubMed ID: 9403252 [TBL] [Abstract][Full Text] [Related]
11. Mycobactericidal and tuberculocidal activity of Korsolex AF, an amine detergent/disinfectant product. Hernández A; Martró E; Matas L; Jiménez A; Ausina V J Hosp Infect; 2005 Jan; 59(1):62-6. PubMed ID: 15571855 [TBL] [Abstract][Full Text] [Related]
12. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
13. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum. Barrett MS; Jones RN; Erwin ME; Koontz FP Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233 [TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains]. Thomas L; Naumann P; Crea A Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424 [TBL] [Abstract][Full Text] [Related]
15. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods. Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096 [TBL] [Abstract][Full Text] [Related]
16. [Reactivities of various mycobacteria species against DNA probes (Gen-Probe Rapid Diagnostic System) specific to Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare]. Tomioka H; Sato K; Saito H; Tasaka H Kekkaku; 1991 Jun; 66(6):405-11. PubMed ID: 1942722 [TBL] [Abstract][Full Text] [Related]
17. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium terrae: a potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test. Griffiths PA; Babb JR; Fraise AP J Hosp Infect; 1998 Mar; 38(3):183-92. PubMed ID: 9561469 [TBL] [Abstract][Full Text] [Related]